What is the Return on Assets (ROA) of Kobayashi Pharmaceutical Co this year?
The Return on Assets (ROA) of Kobayashi Pharmaceutical Co is 0.08 undefined this year.
Kobayashi Pharmaceutical Co ROA 2024
Kobayashi Pharmaceutical Co ROA
0.08
Ticker
4967.T
ISIN
JP3301100008
WKN
920477
In 2024, Kobayashi Pharmaceutical Co's return on assets (ROA) was 0.08, a -2.84% increase from the 0.08 ROA in the previous year.
Kobayashi Pharmaceutical Co Aktienanalyse
What does Kobayashi Pharmaceutical Co do?
Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the production of health products. Kobayashi Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Kobayashi Pharmaceutical Co's Return on Assets (ROA)
Kobayashi Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Kobayashi Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Kobayashi Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Kobayashi Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Kobayashi Pharmaceutical Co stock
What was the ROA of Kobayashi Pharmaceutical Co compared to the previous year?
The ROA of Kobayashi Pharmaceutical Co has increased by -2.84% compared to the previous year.
What consequences do high ROA have for investors of Kobayashi Pharmaceutical Co?
A high ROA is advantageous for investors of Kobayashi Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Kobayashi Pharmaceutical Co?
A low ROA can be unfavorable for investors of Kobayashi Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Kobayashi Pharmaceutical Co affect the company?
An increase in ROA of Kobayashi Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Kobayashi Pharmaceutical Co impact the company?
A reduction in the ROA of Kobayashi Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Kobayashi Pharmaceutical Co?
Some factors that can influence the ROA of Kobayashi Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Kobayashi Pharmaceutical Co important for investors?
The ROA of Kobayashi Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Kobayashi Pharmaceutical Co take to improve ROA?
To improve ROA, Kobayashi Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Kobayashi Pharmaceutical Co pay?
Over the past 12 months, Kobayashi Pharmaceutical Co paid a dividend of 101 JPY . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Kobayashi Pharmaceutical Co is expected to pay a dividend of 107.77 JPY.
What is the dividend yield of Kobayashi Pharmaceutical Co?
The current dividend yield of Kobayashi Pharmaceutical Co is 1.84 %.
When does Kobayashi Pharmaceutical Co pay dividends?
Kobayashi Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.
How secure is the dividend of Kobayashi Pharmaceutical Co?
Kobayashi Pharmaceutical Co paid dividends every year for the past 23 years.
What is the dividend of Kobayashi Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 107.77 JPY are expected. This corresponds to a dividend yield of 1.96 %.
In which sector is Kobayashi Pharmaceutical Co located?
Kobayashi Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Kobayashi Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Kobayashi Pharmaceutical Co from 3/1/2025 amounting to 59 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
When did Kobayashi Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 3/1/2025.
What was the dividend of Kobayashi Pharmaceutical Co in the year 2023?
In the year 2023, Kobayashi Pharmaceutical Co distributed 90 JPY as dividends.
In which currency does Kobayashi Pharmaceutical Co pay out the dividend?
The dividends of Kobayashi Pharmaceutical Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Kobayashi Pharmaceutical Co
Our stock analysis for Kobayashi Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kobayashi Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Kobayashi Pharmaceutical Co Revenue
- Kobayashi Pharmaceutical Co Net Income
- Kobayashi Pharmaceutical Co P/E
- Kobayashi Pharmaceutical Co P/S
- Kobayashi Pharmaceutical Co EBIT
- Kobayashi Pharmaceutical Co Dividend
- Kobayashi Pharmaceutical Co Stocks
- Kobayashi Pharmaceutical Co Market capitalization
- Kobayashi Pharmaceutical Co Debt
- Kobayashi Pharmaceutical Co Liabilities
- Kobayashi Pharmaceutical Co Equity
- Kobayashi Pharmaceutical Co AAQS
- Kobayashi Pharmaceutical Co Employees
- Kobayashi Pharmaceutical Co ROE
- Kobayashi Pharmaceutical Co ROA
- Kobayashi Pharmaceutical Co ROCE
